关注
Karthik Gourishetti M.Pharm., Ph.D.
Karthik Gourishetti M.Pharm., Ph.D.
Postdoctoral Fellow, University of South Carolina School of Medicine
在 uscmed.sc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems
SB Andugulapati, K Gourishetti, SK Tirunavalli, TB Shaikh, R Sistla
Phytomedicine 78, 153298, 2020
992020
Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats
K Gourishetti, R Keni, PG Nayak, SR Jitta, NA Bhaskaran, L Kumar, ...
International Journal of Nanomedicine, 9265-9282, 2020
612020
Poly (N, N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice
S Havanur, I Batish, SP Cheruku, K Gourishetti, PE JagadeeshBabu, ...
Materials Science and Engineering: C 105, 110094, 2019
532019
Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats
SP Cheruku, GV Ramalingayya, MR Chamallamudi, S Biswas, ...
Cytotechnology 70, 245-259, 2018
502018
Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: Development and in vitro and in vivo evaluations
MR Hirpara, J Manikkath, K Sivakumar, RS Managuli, K Gourishetti, ...
International journal of biological macromolecules 107, 2190-2200, 2018
492018
Evaluation of the aphrodisiac potential of a chemically characterized aqueous extract of Tamarindus indica pulp
A Rai, S Das, MR Chamallamudi, K Nandakumar, R Shetty, M Gill, ...
Journal of Ethnopharmacology 210, 118-124, 2018
422018
Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-κB pathway
SK Tirunavalli, K Gourishetti, RSS Kotipalli, M Kuncha, M Kathirvel, ...
Phytomedicine 92, 153729, 2021
362021
Influence of preparation methods on physicochemical and pharmacokinetic properties of co-amorphous formulations: The case of co-amorphous atorvastatin: Naringin
A Nair, R Varma, K Gourishetti, K Bhat, S Dengale
Journal of Pharmaceutical Innovation 15, 365-379, 2020
352020
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials
VSK Anand, SD Sakhare, KSN Sree, AR Nair, KR Varma, K Gourishetti, ...
European Journal of Pharmaceutical Sciences 123, 124-134, 2018
292018
Terminalia tomentosa Bark Ameliorates Inflammation and Arthritis in Carrageenan Induced Inflammatory Model and Freund’s Adjuvant‐Induced Arthritis Model in …
SR Jitta, P Daram, K Gourishetti, CS Misra, PR Polu, A Shah, ...
Journal of toxicology 2019 (1), 7898914, 2019
252019
Assessment of the in vitro cytotoxicity and in vivo anti-tumor activity of the alcoholic stem bark extract/fractions of Mimusops elengi Linn.
H Kumar, M Savaliya, S Biswas, PG Nayak, N Maliyakkal, ...
Cytotechnology 68, 861-877, 2016
242016
Investigation of anti-inflammatory and anti-arthritic potentials of Terminalia catappa bark using in vitro assays and carrageenan-induced inflammation, complete Freund's …
P Daram, SR Jitta, CS Shreedhara, CS Misra, K Gourishetti, R Lobo
South african journal of botany 141, 313-321, 2021
182021
Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential
N Pathak, SP Cheruku, V Rao, RJA Vibhavari, S Sumalatha, K Gourishetti, ...
3 Biotech 10, 1-13, 2020
182020
Rutin protects against doxorubicin-induced cognitive dysfunction while retaining the anticancer Potential of dox in a murine model of N-methyl-N-nitrosourea–induced mammary …
GV Ramalingayya, K Gourishetti, PG Nayak, CM Rao, A Kishore, ...
Journal of Environmental Pathology, Toxicology and Oncology 38 (2), 2019
142019
Role of statins in new-onset diabetes mellitus: the underlying cause, mechanisms involved, and strategies to combat
R Keni, A Sekhar, K Gourishetti, PG Nayak, M Kinra, N Kumar, ...
Current Drug Targets 22 (10), 1121-1128, 2021
132021
Terminalia tomentosa bark ameliorates inflammation and arthritis in carrageenan induced inflammatory model and freund’s adjuvant-induced arthritis model in rats
SJ Reddy, P Daram, PP Rao, A Shah, CS Shreedhara, R Lobo, ...
Journal of Toxicology 2019 (1), 1-11, 2019
132019
Naringin ameliorates doxorubicin-induced neurotoxicity in vitro and cognitive dysfunction in vivo
GV Ramalingayya, PG Nayak, RR Shenoy, SB Mallik, K Gourishetti, ...
Pharmacognosy Magazine 14 (55s), 2018
132018
Diabetic wound healing approaches: an update
R Keni, F Begum, K Gourishetti, GL Viswanatha, PG Nayak, ...
Journal of Basic and Clinical Physiology and Pharmacology 34 (2), 137-150, 2023
112023
Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial …
U Kanojia, SG Chaturbhuj, R Sankhe, M Das, R Surubhotla, N Krishnadas, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021
112021
Preclinical pharmacokinetics and biodistribution studies of asenapine maleate using novel and sensitive RP–HPLC method
RS Managuli, K Gourishetti, RR Shenoy, KB Koteshwara, MS Reddy, ...
Bioanalysis 9 (14), 1037-1047, 2017
112017
系统目前无法执行此操作,请稍后再试。
文章 1–20